Patent Classification

Drug Delivery System, Microspheres/Microcapsules/Microparticles

1. Process for embolization using swellable and deformable microspheres
    
2. Semi-crystalline absorbable microspheres
    
3. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
    
4. Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome
    
5. Insulin highly respirable microparticles
    
6. Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
    
7. Microparticles with adsorbed polypeptide-containing molecules
    
8. Method for the preparation of purified microparticles
    
9. Preparations for the application of anti-inflammatory agents
    
10. Method and apparatus for producing particles using supercritical fluid
     
11. Solid dispersion compositions
     
12. Targeted delivery of bioactive factors to the systemic skeleton
     
13. Sustained-release microparticle preparation of human growth hormone and process for producing thereof
     
14. Production of microspheres
     
15. Microparticles
     
16. Injectable microspheres for tissue construction
     
17. Compositions and methods for biodegradable microspheres as carriers of bioactive substances
     
18. Genipin-crosslinked gelatin microspheres as drug carrier
     
19. Fenofibrate microparticles
     
20. Induced phase transition method for the production of microparticles containing hydrophilic active agents
     
21. Triggered release from proteinoid microspheres
     
22. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
     
23. Electroactive microspheres and methods
     
24. Mesoporous compositions for use in drug delivery
     
25. Multi-layered microcapsules and method of preparing same
     
26. Production of polyelectrolyte capsules by surface precipitation
     
27. Microprecipitation method for preparing submicron suspensions
     
28. Micronized freeze-dried particles
     
29. Lactic acid polymer and process for producing the same
     
30. Drug delivery system for hydrophobic drugs
     
31. Prolonged release microspheres for injectable administration
     
32. Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
     
33. Immediate release eplerenone compositions
     
34. Composition containing porous microparticle impregnated with biologically-active compound for treatment of infection
     
35. Sustained release hydrophobic bioactive PLGA microspheres
     
36. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
     
37. Microspheres containing condensed polyanionic bioactive agents and methods for their production
     
38. Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
     
39. Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
     
40. Controlled drug release system of retinoic acid
     
41. Method to obtain microparticles
     
42. Real time monitoring of small particle dissolution by way of light scattering
     
43. Process for generating multilayered particles
     
44. Stable shaped particles of crystalline organic compounds
     
45. Microcapsules and processes for making the same using various polymers and chitosans
     
46. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
     
47. Micro-particulate and nano-particulate polymeric delivery system
     
48. Method for production of microcapsules
     
49. Method of producing submicron particles of a labile agent and use thereof
     
50. Spray-dried microparticles and their use as therapeutic vehicles
     
51. Methods and compositions for enhanced delivery of bioactive molecules
     
52. Spherical microparticles containing linear polysaccharides
     
53. Pharmaceutical composition with extended release of Milnacipran
     
54. Spray drying process and compositions of fenofibrate
     
55. Starch microparticles
     
56. Method of embolization using polyvinyl alcohol microspheres
     
57. Stable particle in liquid formulations
     
58. Starch microcapsules for delivery of active agents
     
59. Fenofibrate pharmaceutical composition having high bioavailability
     
60. Stable shaped particles of crystalline organic compounds
     
61. Polymeric gene delivery system
     
62. Triblock copolymer hollow particles for agent delivery by permeability change
     
63. Microprecipitation method for preparing submicron suspensions
     
64. Microspheres for use in the treatment of cancer
     
65. Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
     
66. Apparatus and method for preparing microparticles
     
67. Prolonged anesthesia in joints and body spaces
     
68. Method for preparing microparticles having a selected polymer molecular weight
     
69. Production of agglomerates of inogatran and the compound inogatran anhydrate
     
70. Stable shaped particles of crystalline organic compounds
     
71. pH-sensitive microcapsules
     
72. Complex of DNA and microparticle of defatted lipid-binding protein for gene therapy
     
73. Variable release microcapsules
     
74. Covalent microparticle-drug conjugates for biological targeting
     
75. Spray-drying process for the preparation of microparticles
     
76. Method of producing sub-micron particles of biologically active agents and uses thereof
     
77. Microparticles for drug delivery across mucosa and the blood-brain barrier
     
78. Encapsulation of bioactive agents
    
    
79. Preparation and use of photopolymerized microparticles
    
    
80. Apparatus and method for preparing microparticles
    
    
81. Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization
    
    
82. Apparatus and method for preparing microparticles
     
    
83. Process for the preparation of a controlled release system
     
    
84. Method of producing morphologically uniform microcapsules and microcapsules produced by this method
     
    
85. Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
     
    
86. Method of producing sub-micron particles of biologically active agents and uses thereof
     
    
87. Aggregates of spherical multivalent metal alginate microparticles and methods of making them
     
    
88. Fibrinogen-coated microspheres
     
    
89. Melt-extruded orally administrable opioid formulations
     
    
90. Polymeric gene delivery system
     
    
91. Starch microcapsules for delivery of active agents
     
    
92. Bioadhesive microspheres and their use as drug delivery and imaging systems
     
    
93. Composition and method of preparing microparticles of water-insoluble substances
     
    
94. Biodegradable polymer matrices for sustained delivery of local anesthetic agents
     
    
95. Methods of forming protein-linked lipidic microparticles, and compositions thereof
     
    
96. Bioadhesive microspheres and their use as drug delivery and imaging systems
     
    
97. Method for preparing microcapsules comprising active materials coated with a polymer and novel microcapsules in particular obtained according to the method
     
    
98. Continuous manufacturing method for microspheres and apparatus
     
    
99. Spherical granule, process for producing the same, and spherical granule preparations using the same
     
    
100. Preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using the same
      
     
101. Microspheres, process for their preparation and their use
      
     
102. Fatty ester combinations
      
     
103. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
      
     
104. Microparticles and their use in wound therapy
      
     
105. Seeded microcapsules for use in tablets, pharmaceutical agents and nutritional compounds
      
     
106. Polymeric microbeads and methods of preparation
      
     
107. Use of microparticles combined with submicron oil-in-water emulsions
      
     
108. Disintegratable microspheres
      
     
109. Method of coating particles and coated spherical particles
      
     
110. Suspensions of microcapsules containing biologically active ingredients and adhesive microspheres
      
     
111. Method for drying microspheres
      
     
112. Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant
      
     
113. Process for the preparation of microspheres containing biologically active components
      
     
114. Preparation of protein microparticles by supercritical fluid precipitation
      
     
115. Hydrophilic microparticles and methods to prepare same
      
     
116. Microsphere encapsulation of gene transfer vectors
      
     
117. pH-sensitive microcapsules
      
     
118. Medicinal and/or nutritional microcapsules for oral administration
      
     
119. Microcapsules containing suspensions of biologically active compounds
      
     
120. Immediate release dosage forms containing microspheres
      
     
121. Preparation of protein microspheres, films and coatings
      
     
122. Tetrahydrolipstatin containing compositions
      
     
123. Spray-dried microparticles and their use as therapeutic vehicles
      
     
124. Delayed drug-releasing microspheres
      
     
125. Process for producing drug-containing microspheres by oil-in-water evaporation process

Drug Delivery System, Molding

1. Dosage forms and methods for oral delivery of progesterone
    
2. Molded capsule superior in strength and stability and method for preparing same
    
   
3. Process for producing solid drug forms having at least two phases

Drug Delivery System, Mucosal/Transmucosal

1. Use of bacterium for manufacture of a vaccine
    
2. Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
    
3. Pharmaceutical composition for transdermal or transmucous administration
    
4. Bioadhesive delivery system for transmucosal delivery of beneficial agents
    
5. Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
    
6. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
    
7. Non-toxic mucosal adjuvant
    
8. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
    
9. Pharmaceutical compositions including low dosages of desmopressin
    
10. Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
     
11. Method of enhancing absorptions of transmucosal administration formulations
     
12. Transmucosal oral delivery device
     
13. Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability
     
14. Dissolvable backing layer for use with a transmucosal delivery device
     
15. Formulations for transdermal or transmucosal application
     
16. Vaccines absorbable by the transmucosal way
     
17. Urogenital or anorectal, transmucosal vaccine delivery system
     
18. Opioid agonist in a fast dispersing dosage form
     
19. Nontoxic mucosal adjuvant
     
20. Inactivated influenza virus vaccine for nasal or oral application
     
21. β-glucans encapsulated in liposomes
     
22. Mucosal originated drug delivery systems and animal applications
     
23. Pharmaceutical composition for application to mucosa
     
24. Vaccines absorbable by the transmucosal way
     
25. Prolonged release bioadhesive therapeutic systems
     
26. Complexes of immunoglobulins polysaccharides for oral and transmucosal absorption
     
27. Two-stage transmucosal medicine delivery system for symptom relief
     
28. Powdery composition for nasal administration
     
29. Plant lectins as mucosal adjuvants
     
30. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
     
31. Inactivated influenza virus vaccine for nasal or oral application
     
32. Compositions having improved delivery of actives
     
33. Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
     
34. Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
     
35. Ciclesonide contained pharmaceutical composition for application to mucosa
     
36. Sprayable analgesic composition and method of use
     
37. Opioid agonist in a fast dispersing dosage form
     
38. Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption
     
39. Oromucosal cytokine compositions and uses thereof
     
40. Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use
     
41. Nicotine mucosal spray
     
42. Vaccine compositions for mucosal delivery
     
43. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
     
44. Oral transmucosal delivery
     
45. Microparticles for drug delivery across mucosa and the blood-brain barrier
     
46. Transmucosal formulations of levosimendan
    
    
47. Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition
    
    
48. Two-stage transmucosal medicine delivery system for symptom relief
    
    
49. Methods of inducing mucosal immunity
    
    
50. Transmucous absorption enhancer
     
    
51. Gum pad for delivery of medication to mucosal tissues
     
    
52. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
     
    
53. Pharmaceutical preparation applicable to mucosal surfaces and body tissues
     
    
54. Oral transmucosal drug dosage using solid solution
     
    
55. Frozen product and method of oral delivery of active ingredients
     
    
56. Pharmaceutical composition containing acid addition salt of basic drug
     
    
57. Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
     
    
58. Methods and apparatus for improved administration of pharmaceutically active compounds
     
    
59. Method for facilitating transmucosal delivery of steroidal active agents
     
    
60. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
     
    
61. Tocopherol compositions for delivery of biologically active agents
     
    
62. Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
     
    
63. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
     
    
64. Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces
     
    
65. DNA vaccines for eliciting a mucosal immune response
     
    
66. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
     
    
67. Mucosal administration of substances to mammals
     
    
68. Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
     
    
69. Mucosal administration of pneumococcal antigens
     
70. Composition for delivering bioactive agents for immune response and its preparation
     
    
71. Mucosal administration of substances to mammals (*Large document -- long loading time)
     
    
72. Use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability

Drug Delivery System, Multi-particulates/Granules/Spheroids

1. Galenic formulation for colon-targeted delivery of active ingredients
    
2. Pharmaceutically active particles of a monomodal particle size distribution and method
    
3. Formulation for spray-drying large porous particles
    
4. Orally administrable opioid formulations having extended duration of effect
    
5. Morphine sulphate microgranules, method for preparing same and compositions containing same
    
6. Powder-layered oral dosage forms
    
7. Timed pulsatile drug delivery systems
    
8. Sustained release ionic conjugate
    
9. Multiparticulate modified release composition
    
10. Multiphase active ingredient-containing formulations
     
11. Melt-extrusion multiparticulates
     
12. Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use
     
13. Quetiapine granules
     
14. Layering process for multiparticulate dosage form
     
15. Melt-extrusion multiparticulates
     
    
16. Process for making submicron particles
     
    
17. Method for gene therapy using nucleic acid loaded polymeric microparticles
     
    
18. Sustained-release preparation utilizing thermal change and process for the production thereof
     
    
19. Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
     
    
20. Particles with modified physicochemical properties, their preparation and uses
     
    
21. Proceeding for the preparation of the prolonged action granule compound containing 4-nitro-2-phenoxymethanesulfonanilide
     
    
22. Composite gel microparticles as active principle carriers
     
    
23. Processes to generate submicron particles of water-insoluble compounds
     
    
24. Particulate support matrix for making a rapidly dissolving dosage form
     
    
25. Sustained release compositions and a method of preparing pharmaceutical compositions
     
    
26. Core substance-containing calcium microparticles and methods for producing the same
     
    
27. Microcrystalline cellulose particles having active core
     
    
28. Spheroids containing tiagabine, preparation process and pharmaceutical compositions
     
    
29. Flash flow processing of thermoplastic polymers and products made therefrom
     
    
30. Extended release acetaminophen particles
     
    
31. Sustained release particles
     
    
32. Spheroids, preparation process and pharmaceutical compositions
     
    
33. Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
     
    
34. Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production
     
    
35. Oral morphine multiparticulate formulation
     
    
36. Sustained release heterodisperse hydrogel systems-amorphous drugs
     
    
37. Hydrophilic microparticles and methods to prepare same
     
    
38. Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
     
    
39. Treatment using prostoglandin and particulate formulations
     
    
40. Sustained-release granular preparations and production process thereof
     
    
41. Biodegradable microparticles for the sustained delivery of therapeutic drugs
     
    
42. Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
     
    
43. Preparation of pharmaceutically active particles
     
    
44. Recipient-dosage delivery system
     
    
45. Extruded multi-particulates

Drug Delivery System, Multi-Stage

1. Oral pulsed dose drug delivery system
    
2. Timed pulsatile drug delivery systems
    
3. Multiplex drug delivery system suitable for oral administration
    
4. Method for making a multi-stage drug delivery system

Drug Delivery System, Nanocochleate

1. Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents

Drug Delivery System, Nanoparticles/Nanocrystals

1. Targeted cross-linked nanoparticles and their use in vivo gene delivery
    
2. Nanoparticles for protein/peptide delivery and delivery means thereof
    
3. Nanoshells for drug delivery
    
4. Polysaccharide-carbon nanotube complex
    
5. Nanoparticulate fibrate formulations
    
6. Embedded micellar nanoparticles
    
7. Nanocrystal taggants
    
8. Drug delivery system targeting to estrogen receptor over-expressed cells
    
9. Method for making magnetic fluorescent core shell nanoparticles
    
10. Polymeric nanoparticles including olfactive components
     
11. Aqueous suspension of nanoscale drug particles from supercritical fluid processing
     
12. N-glycoside type glycolipids and hollow fiber type organic nanotubes made of the same
     
13. Nanoparticulate core shell systems and the use thereof in pharmaceutical and cosmetic preparation
     
14. Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
     
15. Self assembled nanostructures and methods for preparing the same
     
16. Nanoclusters for delivery of therapeutics
     
17. Nanotubes for cancer therapy and diagnostics
     
18. Nanoparticles for protein drug delivery
     
19. Butyl lactate emulsions for the precipitation of water-insoluble drug nanoparticles
     
20. Photosensitizer functionalised nanoparticles
     
21. Nanoparticles for protein drug delivery
     
22. Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting
     
23. Nanoparticles for protein drug delivery
     
24. Cell scaffold matrices with incorporated therapeutic agents
     
25. Calcium phosphate nanoclusters and their applications
     
26. Use of targeted cross-linked nanoparticles for in vivo gene delivery
     
27. Biodegradable polymeric nanocapsules and uses thereof
     
28. Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles
     
29. Nanoparticulate compositions having lysozyme as a surface stabilizer
     
30. Nanoparticles for protein/peptide delivery and delivery means
     
31. Use of nanoparticles for the DNA administration to a target organ
     
32. Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
     
33. Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions
     
34. Methods and products for delivering biological molecules to cells using multicomponent nanostructures
     
35. Nanoparticle delivery vehicle
     
36. Nanoparticles for protein drug delivery
     
37. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
     
38. Nanoparticle vaccines
     
39. Nanoparticles for protein drug delivery
     
40. Nanoparticulate fibrate formulations
     
41. Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
     
42. Polymeric nanoparticles including olfactive components
     
43. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
     
44. Nanoparticle delivery system
     
45. Method for preparation of block copolymeric nanoparticles
     
46. Stabilized particle dispersions containing nanoparticles
     
47. Nanoparticulate megestrol formulations
     
48. Water soluble nanoparticles of hydrophilic and hydrophobic active materials and an apparatus and method for their production
     
49. Process for producing nanometer particles by fluid bed spray-drying
     
50. Functionalized encapsulated fluorescent nanocrystals
     
51. Drug targeting system, method of its preparation and its use
     
52. Nanoscale particles synthesized within an assembled virion
     
53. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
     
54. Microprecipitation method for preparing submicron suspensions
     
55. Microprecipitation method for preparing submicron suspensions
     
56. Composite nanospheres and their conjugates with biomolecules
     
57. Use of nanoscalar water-soluble .beta.-(1,3) glucans
     
58. Preparation of submicron sized nanoparticles via dispersion lyophilization
     
59. Nanoparticles having oligonucleotides attached thereto and uses therefor
     
60. Liquid droplet aerosols of nanoparticulate drugs
     
61. Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
     
62. Micro-particulate and nano-particulate polymeric delivery system
     
63. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
     
64. Methods and compositions for enhanced delivery of bioactive molecules
     
65. Biopolymer nanoparticles
     
66. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
     
67. Reactive nanoparticles as destructive adsorbents for biological and chemical contamination
     
68. Method of making nanoparticles of substantially water insoluble materials
     
69. Purification of functionalized fluorescent nanocrystals
     
    
70. Method for producing nanocapsules with crosslinked protein-based walls nanocapsules thereby obtained and cosmetic, pharmaceutical and food compositions using same
     
    
71. Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
     
    
72. Nebulized aerosols containing nanoparticle dispersions
     
    
73. Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
     
    
74. Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors
     
    
75. Nanospheres comprising a biocompatible polysaccharide
     
    
76. Therapeutic nanospheres
     
    
77. Injectable formulations of nanoparticulate naproxen
     
    
78. Vitamin B₁₂ derivatives and methods for their preparation
     
    
79. Stabilized nanoparticles which may be filtered under sterile conditions
     
    
80. Stabilized nanoparticles which are filterable under sterile conditions
     
    
81. Drug targeting to the nervous system by nanoparticles
     
    
82. Functionalized nanocrystals and their use in detection systems
     
    
83. Methods and compositions useful for administration of chemotherapeutic agents
     
    
84. Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers (Patent: 6,068,858)
     
    
85. Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
     
    
86. Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
     
    
87. Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds

Drug Delivery System, Non-aqueous

1. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
    
2. Non-aqueous protic peptide formulations
    
   
3. Water-miscible pharmaceutical compositions
    
   
4. Nonaqueous compositions for parenteral administration

Drug Delivery System, Ophthalmic/Periocular

1. Ophthalmic lenses capable of sustained drug release and preservative solutions therefor
    
2. Three layer artificial tear formulation
    
3. Ophthalmic compositions containing a synergistic combination of two polymers
    
4. VEGF antagonist formulations suitable for intravitreal administration
    
5. Transscleral delivery
    
6. Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions 
    
7. Method and kit for moisturizing the surface of the eye
    
8. Ophthalmic compositions containing a synergistic combination of three polymers
    
9. Trans-scleral drug delivery method and apparatus
    
10. Periocular drug delivery for diabetic retinopathy
     
11. Ophthalmic compositions containing galactomannan polymers and borate
     
12. Ophthalmic formulation with novel gum composition
     
13. Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
     
14. Ocular solutions
     
15. Lubricious ophthalmic solutions
     
16. Use of lacrophyl preparation in eye drops containing therapeutically active compounds
     
17. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
     
18. Ophthalmic lubricating solution adapted for use in lasik surgery
     
19. Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
     
20. Ophthalmic irrigating solution adapted for use in lasik surgery
     
21. Method for the treatment of bacterial eye infections
     
22. Ophthalmic compositions containing galactomannan polymers and borate
     
23. Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
     
24. Ophthalmic compositions
     
25. Autoclavable pharmaceutical compositions containing a chelating agent
     
26. Packaged ophthalmic perfusate and cleaning fluid bag
     
27. Intraocular lens containing releasable medication
     
28. Reversible gelling system for ocular drug delivery
     
29. Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
     
30. Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
     
31. Ophthalmic compositions containing galactomannan polymers and borate
     
32. Compositions and methods for treating eye discomfort
     
33. Ophthalmic composition with regulated viscosity
     
34. Use of borate-polyol complexes in ophthalmic compositions
     
35. Anti-inflammatory eye drop
     
36. Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
     
37. Autoclavable pharmaceutical compositions containing a chelating agent
     
38. Controlled-release biocompatible ocular drug delivery implant devices and methods
     
    
39. Process for preparing of aqueous formulation for ophthalmic use
     
    
40. Ocular insert
     
    
41. Gelling ophthalmic compositions containing xanthan gum
     
    
42. Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof
     
    
43. Eye dropper with illuminated tip
     
    
44. Conjunctival inserts for topical delivery of medication or lubrication
     
    
45. Gelling ophthalmic compositions containing xanthan gum
     
    
46. Sustained release ophthalmic compositions containing water soluble medicaments
     
    
47. Ophthalmic solution
     
    
48. Use of borate-polyol complexes in ophthalmic compositions
     
    
49. O/W emulsion composition for eye drops
     
    
50. Ophthalmic solutions viscosified with tamarind seed polysaccharide
     
    
51. Drug composition comprising albumin as active ingredient
     
    
52. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced
     
    
53. Aqueous ophthalmic solution containing apafant as active ingredient
     
    
54. Patent on use of aloe vera ophthalmic solution for treatment of the dry eye syndrome, inflammations, ulcerations, alkaline or acid burns, infections, and cataracts
     
    
55. Ophthalmic compositions
     
    
56. Liposome eye drops

Drug Delivery System, Oral

1. Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption
    
2. Orodispersible solid pharmaceutical form
    
3. Taste masked liquid pharmaceutical compositions
    
4. Easy to swallow oral medicament composition
    
5. Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
    
6. Orally deliverable supramolecular complex
   
   
7. Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity
    
   
8. Stabilized aspirin compositions and method of preparation for oral and topical use
    
   
9. Oral administration of adenosine analogs
    
   
10. Spill resistant pharmaceutical compositions in semi-solid form
     
    
11. Pharmaceutical compositions for oral use including an NSAID and ceramides
     
    
12. Delivery system for an oral care substance using a permanently deformable strip of material
     
    
13. Antifungal oral composition containing itraconazole and process for preparing same
     
    
14. Pharmaceutical formulations of taxanes
     
    
15. Pharmaceutical composition with anaesthetic effect
     
    
16. Composition and means for treating dry mouth
     
    
17. Pharmaceutical compositions containing lamivudine
     
    
18. Oral-administration forms of a medicament containing pantoprazol
     
    
19. NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
     
    
20. Oral delivery of discrete units
     
    
21. Rapamycin formulations for oral administration
     
    
22. Composition for the delivery of orally administered drugs and other substances
     
    
23. Orally administrable opioid formulations having extended duration of effect
     
    
24. Method of drug delivery and coated oral dosage forms for use in the method
     
    
25. Cough drop sucker with cover
     
    
26. Multiple unit oral pharmaceutical formulations
     
    
27. Oral solid dosage forms, methods of making same and compositions thereof
     
    
28. Oral dosage-forms containing a .beta.-lactam antibiotic
     
    
29. Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
     
    
30. Composition for oral administration containing pyridazinone compounds
     
    
31. Oral preparation for patients with chronic renal insufficiency, method of making and use
     
    
32. Jellied medicinal composition for oral administration
     
    
33. Galenical formulations
     
    
34. Peroral composition for controlled release in the lower gastrointestinal tract